CDC Continuing Education 

Colorectal cancer (CRC) is the second leading cause of cancer death for men and women combined in New Hampshire and in the U.S.  However, CRC is a preventable disease.  For people who do develop CRC, it is a treatable disease when detected early.  We can maximize the number of lives saved through CRC screening by screening more people and ensuring that the screening is done well, and at appropriate intervals. Increasing proper screening in disparate populations is a goal included in the NH Comprehensive Cancer Control Plan.

High-quality screening tests help find precancerous polyps (small growths on the lining of the colon) so they can be painlessly removed before they have a chance to turn into cancer. This prevents CRC from developing.  CRC screening tests can also find CRC early when treatment is most effective.

Screening for Colorectal Cancer: Optimizing Quality is a CDC-sponsored continuing education course offered online to provide guidance and tools for clinicians on the optimal ways to implement screening and surveillance for CRC.  This course was developed by a group of nationally recognized experts in CRC screening, including primary care clinicians, gastroenterologists, and leaders in public health programs and research.  There are two versions, one for primary care providers and one for clinicians who perform colonoscopies. 

The primary care version of Screening for Colorectal Cancer: Optimizing Quality is intended for primary care physicians, nurses, and other health professionals.  This three-part course is approximately two hours long and provides 2.25 CME, 2.0 CNE, or 0.2 CEU.  It covers the importance of offering both stool blood testing and colonoscopy as CRC screening options for average risk patients, selecting appropriate CRC testing for each patient, and identifying the elements of a high-quality stool blood testing program and high-quality colonoscopy  testing.

The endoscopist version is intended for physicians who perform colonoscopy, nurses, and other health professionals.  This two-part course is approximately 90 minutes long and provides 1.5 CME, 1.4 CNE, or 0.1 CEU.  It covers the importance of selecting appropriate CRC testing for each patient, discussing the importance of a good preparation and ways to achieve a good preparation, listing the procedure and polyp characteristics that should be documented in the colonoscopy report, and listing key quality indicators that should be monitored to improve colonoscopy performance.

Click here http://www.cdc.gov/cancer/colorectal/quality/ to view the presentation (available in narrated versions) for Screening for Colorectal Cancer: Optimizing Quality (CME).